Search Videos and More
News
ASCO Genitourinary Cancer Symposium 2025: Fox Chase Advances Cancer Prevention, Research, and Potential Cures
This year, Fox Chase faculty and Fellows presented research that revealed tangible benefits for genitourinary cancer patient outcomes and quality of life.
News
A Video Is Worth a Thousand Words in Preparing Patients for Melanoma Surgery
Course
Monthly Multi-Institutional Hematopathology Interesting Case Conference
Please join us for our next Monthly Multi-Institutonal Hematopathology Interesting Case Conference (MHICC). A collaborative meeting that brings together pathologists, clinicians and researchers from renowned institutions to discuss challenging and educational hematopathology cases
News
A tragic death becomes a life force.
“A defining moment in my life was when my father was diagnosed with glioblastoma. At the time, we lived in New York’s Hudson Valley, and no area medical center offered treatment for a serious and complicated diagnosis like his. The only available therapy was in Manhattan, so at age 16, with just a learner’s permit, I drove my dad into the city to fight for his life while I maneuvered the George Washington Bridge as a novice driver,” says James P. Nitzkorski, MD, FACS, FSSO, a former Surgical Oncology Fellow at Fox Chase Cancer Center, and now, a surgical oncologist at Nuvance Health and Program Director for the General Surgery Residency at Vassar Brothers Medical Center, both in Poughkeepsie, NY. His father’s experience p
News
Plan Before a Treatment Road Ends
News
Fox Chase Cancer Center Researchers Review Guidelines for Therapies Given to Melanoma Patients Before and After Initial Treatment
Jeffrey Farma, MD, FACS, Chair of the Department of Surgery at Fox Chase Cancer Center, and a team of colleagues recently published an updated review of guidelines governing the use of neoadjuvant and adjuvant therapy for patients with melanoma.
Symposium
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available. Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.
News
Jay Simhan, MD, FACS Named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University
Jay Simhan, MD, FACS, has been named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University.
News
The Hoofbeats You Hear May Be a Zebra: Cancer Diagnoses in Ages 18 to 39
At Fox Chase, the Young Adult Cancer Program has been developed as a comprehensive, robust resource to help young adults and their doctors face the challenges of cancer just as someone begins to navigate life’s milestones—finishing school, beginning careers, attaining financial stability, and starting families. It’s a clinical and a psychosocial maelstrom.
News
For Some Rectal Cancer Patients, Prophylactic Chemotherapy Meant a 79% Organ Preservation Result
For patients with cancer in the lower part of the rectum that has not spread to the lymph nodes, chemotherapy administered before localized surgery is an effective method of preserving a patient’s surrounding organs, according to a new study by researchers at Fox Chase Cancer Center.
News
Upending NSCLC Survival Rates with New Care Paradigms
For years, researcher-clinician Hossein Borghaei, DO, MS, Chief, Thoracic Medical Oncology, Fox Chase Cancer Center, has been at the forefront of global exploration into the genetic, proteomics, and cellular landscape of non-small cell lung cancer (NSCLC). These efforts have led to the development of innovative clinical trials and new therapeutic paradigms.
News
Fox Chase Cancer Center and Temple Health Physicians and Scientists Present Research at the American Society of Hematology 2024 Annual Meeting
Fox Chase Cancer Center and Temple Health physicians and scientists participated in the presentation and discussion of eight research projects at the American Society of Hematology (ASH) 2024 Annual Meeting, held this past December in San Diego.